Materialise NV MTLS reported first-quarter FY23 revenue growth of 24.4% year-on-year to $71.65 million (€65.89 million), beating the consensus of $65.89 million.
- EPS of $0.07 beat the consensus loss of $(0.08).
- Revenue from Materialise Software segment increased 8.3% Y/Y to €11.35 million, Materialise Medical rose 32.5% to €24.32 million, and Materialise Manufacturing segment rose 25.2% to €30.22 million.
- The gross margin expanded by 140 bps to 55.9%. The adjusted EBITDA margin increased by 530 bps to 15.6%.
- Materialise held €141.72 million in cash and equivalents.
- Executive Chairman Peter Leys commented, saying, "Our consolidated revenues increased more than 24%, boosted by the very strong growth of Materialise Medical and Materialise Manufacturing revenues, by 33% and 25%, respectively, and further supported by a solid revenue uptake at Materialise Software of more than 8%. During the quarter, our Adjusted EBITDA increased 89% to 10,310 kEUR, mainly because of scaling effects."
- Outlook: Materialise expects FY23 revenue to be closer to the high end of initial guidance of €255 million - €260 million.
Price Action: MTLS shares traded higher by 12.8% at $8.79 on the last check Thursday.
Now Read: Microsoft's Mega Paychecks: Staggering Pre-Layoff Salaries Of Managers, Analysts, And Engineers
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in